MEDICINA
DEPARTAMENTO
Hospital de Cabueñes
Gijón, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cabueñes (46)
2024
-
Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis
Autoimmunity Reviews
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”
Journal of the American Academy of Dermatology
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
2022
-
Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E180-E188
2021
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
HIV/HBV coinfection: Temporal trends and patient characteristics, Spain, 2002 to 2018
Eurosurveillance, Vol. 26, Núm. 25
-
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880
2020
-
Longterm efficacy and safety of monotherapy versus combination therapy in systemic sclerosis-associated pulmonary arterial hypertension: A retrospective RESCLE registry study
Journal of Rheumatology, Vol. 47, Núm. 1, pp. 89-98
-
Serodiscordant patients with systemic sclerosis: When antibody does not correspond to skin involvement
Clinical and Experimental Rheumatology, Vol. 38, pp. S106-S114
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia
International Journal of Tuberculosis and Lung Disease, Vol. 23, Núm. 10, pp. 1100-1106
-
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes
Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1455-1457
-
Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry
Clinical Rheumatology, Vol. 38, Núm. 4, pp. 1117-1124
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135